Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications

OMBRELLO M. J., ARTHUR V. L., REMMERS E. F., Hinks A., TACHMAZIDOU I., Grom A. A., ...Daha Fazla

ANNALS OF THE RHEUMATIC DISEASES, cilt.76, sa.5, 2017 (SCI-Expanded) identifier identifier identifier

Özet

Objectives Juvenile idiopathic arthritis (JIA) is a heterogeneous group of conditions unified by the presence of chronic childhood arthritis without an identifiable cause. Systemic JIA (sJIA) is a rare form of JIA characterised by systemic inflammation. sJIA is distinguished from other forms of JIA by unique clinical features and treatment responses that are similar to autoinflammatory diseases. However, approximately half of children with sJIA develop destructive, long-standing arthritis that appears similar to other forms of JIA. Using genomic approaches, we sought to gain novel insights into the pathophysiology of sJIA and its relationship with other forms of JIA.